[与脑瘤相关的焦点的治疗方法]
N V Zhulin1, I A Zhidkova2, D R Naskhletashvili3
1Municipal Clinical Hospital No. 67 named after L.A. Vorokhobov, Moscow, Russia.
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
|October 6, 2025
概括
大脑瘤 (BT) 患者的症存在独特的挑战. 新的抗药物 (AED) 为这些复杂的病例中控制发作提供了改进的治疗选择.
科学领域:
- 神经学 神经学
- 在瘤学瘤学.
- 神经科学是一个神经科学.
背景情况:
- 是脑瘤 (BTs) 的常见并发症,影响患者的预后.
- 发作可能是BTs的初始症状,或使其管理复杂化.
研究的目的:
- 审查当前关于治疗与脑瘤相关的的文献.
- 探索最佳的抗药物 (AED) 选择和管理策略,用于BT相关的.
主要方法:
- 国际和俄罗斯研究的综合文献综述.
- 对治疗方法的分析,AED的选择,以及与化疗的药物相互作用.
主要成果:
- 新的抗药物 (AED) 为管理BT相关提供了更好的机会.
- 考虑AED和化疗剂之间的药物相互作用至关重要.
结论:
- 有效管理与BT相关的需要跨学科的方法.
- 仔细选择AED,考虑有效性,安全性和药物相互作用,对于改善患者的治疗结果至关重要.
相关概念视频
Antiepileptic Drugs: Glutamate Antagonists
851
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
851
Epilepsy and Seizures: Overview
1.1K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.1K
Antiepileptic Drugs: GABAergic Pathway Potentiators
1.1K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.1K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
785
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
785
Antiepileptic Drugs: Sodium Channel Blockers
1.5K
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
1.5K
Electroconvulsive Therapy
771
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
771


